Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Optimal Timing for PPI Administration with Anti-TB Medications and Levofloxacin

Drug Interaction Considerations

  • The Centers for Disease Control and Prevention recommends that PPIs should be administered at least 2 hours before or after levofloxacin to prevent decreased absorption of the fluoroquinolone 1, 2
  • Fluoroquinolones like levofloxacin have significantly decreased absorption when administered with medications containing divalent cations (including antacids and PPIs) 1, 2
  • The critical timing requirement is that levofloxacin must not be administered within 2 hours of PPIs to maintain therapeutic efficacy 1, 3
  • First-line anti-TB drugs (isoniazid, rifampin, ethambutol, pyrazinamide) do not have significant absorption interactions with PPIs 4, 5
  • Rifampin and isoniazid are primarily metabolized by the liver, so their absorption is not significantly affected by gastric pH changes caused by PPIs 5
  • Ethambutol and pyrazinamide can be administered without specific timing considerations related to PPIs 5

Special Considerations

  • For patients with creatinine clearance <30 mL/min or on hemodialysis, levofloxacin dosing should be adjusted to 750-1000 mg three times weekly (not daily) 4, 5
  • PPI timing remains the same (2-hour separation) for patients with renal impairment 5
  • Ethambutol and pyrazinamide also require dosing adjustment to three times weekly for patients with renal impairment 5
  • Levofloxacin levels are not significantly affected by hepatic disease, so standard dosing and timing can be maintained 1, 2
  • PPI metabolism may be altered in severe hepatic disease, potentially requiring dose adjustment, but timing recommendations remain unchanged 4